Mercer Global Advisors Inc Eledon Pharmaceuticals, Inc. Transaction History
Mercer Global Advisors Inc
- $35.2 Billion
- Q1 2024
A detailed history of Mercer Global Advisors Inc transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Mercer Global Advisors Inc holds 16,726 shares of ELDN stock, worth $44,156. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,726
Previous 16,726
-0.0%
Holding current value
$44,156
Previous $30,000
13.33%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding ELDN
# of Institutions
32Shares Held
9.61MCall Options Held
500Put Options Held
1.4K-
Bvf Inc San Francisco, CA4.33MShares$11.4 Million0.27% of portfolio
-
Armistice Capital, LLC New York, NY2.3MShares$6.06 Million0.06% of portfolio
-
Vanguard Group Inc Valley Forge, PA969KShares$2.56 Million0.0% of portfolio
-
Woodline Partners LP San Francisco, CA652KShares$1.72 Million0.01% of portfolio
-
Ensign Peak Advisors, Inc Salt Lake City, UT443KShares$1.17 Million0.0% of portfolio
About Eledon Pharmaceuticals, Inc.
- Ticker ELDN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 13,756,800
- Market Cap $36.3M
- Description
- Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...